Immunohistochemical expression of SPARC in odontogenic keratocysts: a comparative study with other odontogenic cysts

Sopee Poomsawat1, Sirada Choakdeewanitthumrong1, Sirima Sanguansin2

  • 1Department of Oral and Maxillofacial Pathology, Faculty of Dentistry, Mahidol University, 6 Yothi Street, Ratchathewi, Bangkok, 10400, Thailand.

BMC Oral Health
|February 12, 2024
PubMed
Abstract

Insights

Secreted protein acidic and rich in cysteine (SPARC) expression is significantly higher in odontogenic keratocysts (OKCs) compared to other cyst types. This finding suggests SPARC may contribute to the aggressive nature of OKCs.

Area of Science:

  • Oral pathology
  • Oncology
  • Biochemistry

Background:

  • Secreted protein acidic and rich in cysteine (SPARC) influences tumor aggressiveness.
  • Odontogenic keratocyst (OKC) exhibits aggressive behavior, but SPARC's role is understudied.
  • Limited research exists on SPARC expression in OKCs.

Purpose of the Study:

  • To characterize SPARC expression in OKCs.
  • To compare SPARC expression in OKCs with less aggressive odontogenic cysts.
  • To investigate the association between SPARC and OKC's aggressive behavior.

Main Methods:

  • Immunohistochemistry used to evaluate SPARC expression.
  • SPARC was assessed in 38 OKCs, 39 radicular cysts (RCs), 35 dentigerous cysts (DCs), and 14 calcifying odontogenic cysts (COCs).
  • Staining intensity and percentage of positive cells in the epithelial lining and cystic wall were scored.

Main Results:

  • SPARC was generally not detected in the epithelial lining, except in COCs' ghost cells.
  • Fibroblasts in the cystic wall were the primary SPARC-positive cells.
  • OKCs exhibited significantly higher SPARC expression in the cystic wall compared to RCs, DCs, and COCs.

Conclusions:

  • Elevated SPARC expression in OKCs compared to other cysts.
  • SPARC may play a role in the aggressive behavior of odontogenic keratocysts.
  • Further research is warranted to elucidate SPARC's specific mechanisms in OKC progression.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...